Results 1 to 10 of about 48,457 (271)

Murine models of idiopathic inflammatory myopathy

open access: yesImmunological Medicine, 2023
Idiopathic inflammatory myopathies (IIMs) are characterized by inflammation of muscles and other organs. Several myositis-specific autoantibodies (MSAs) have been identified in IIMs and were found to be associated with distinct clinical features ...
Risa Konishi   +2 more
doaj   +2 more sources

Belimumab treatment of adult idiopathic inflammatory myopathy. [PDF]

open access: yesRheumatology (Oxford), 2023
OBJECTIVE To evaluate belimumab addition to standard of care (SoC) in patents with refractory Idiopathic Inflammatory Myopathy (IIM). METHODS We conducted a 40-week multicentre randomized, double-blind, placebo-controlled trial with 1:1 IV belimumab 10 
Marder G   +9 more
europepmc   +2 more sources

The value of myositis-specific autoantibodies in the diagnosis of idiopathic inflammatory myopathy and tumor risk prediction [PDF]

open access: yesJournal of International Medical Research
Objective To investigate the value of myositis-specific autoantibodies in the diagnosis of idiopathic inflammatory myopathy and tumor risk prediction in patients with clinically suspected idiopathic inflammatory myopathy. Methods This retrospective study
Lili Shi   +5 more
doaj   +2 more sources

Idiopathic inflammatory myopathy and non-coding RNA [PDF]

open access: yesFrontiers in Immunology, 2023
Idiopathic inflammatory myopathies (IIMs) are common autoimmune diseases that affect skeletal muscle quality and function. The lack of an early diagnosis and treatment can lead to irreversible muscle damage.
Yang Yang   +5 more
doaj   +2 more sources

Muscle Tissue Transcriptome of Idiopathic Inflammatory Myopathy Reflects the Muscle Damage Process by Monocytes and Presence of Skin Lesions. [PDF]

open access: yesArthritis Rheumatol
We aim to investigate transcriptomic and immunophenotypic features of muscle specimens from patients with idiopathic inflammatory myopathy (IIM).
Izuka S   +21 more
europepmc   +2 more sources

Outcome of COVID-19 in patients with idiopathic inflammatory myopathy during the Omicron wave in China: A longitudinal observational study. [PDF]

open access: yesPLoS ONE
ObjectiveThe coronavirus disease pandemic brought unknown challenges to patients with idiopathic inflammatory myopathy, who are often heavily immunosuppressed and have comorbidities.
Ying Li   +9 more
doaj   +2 more sources

Efficacy and Safety of Subcutaneous Abatacept Plus Standard Treatment for Active Idiopathic Inflammatory Myopathy: Phase 3 Randomized Controlled Trial. [PDF]

open access: yesArthritis Rheumatol
Our objective was to evaluate the efficacy and safety of subcutaneous (SC) abatacept and standard of care (SOC) for the treatment of idiopathic inflammatory myopathy (IIM) over 52 weeks.
Aggarwal R   +5 more
europepmc   +2 more sources

The advance of idiopathic inflammatory myopathy

open access: greenChinese Journal of Contemporary Neurology and Neurosurgery, 2016
DOI: 10.3969/j.issn.1672-6731.2016.10 ...
Yun YUAN
doaj   +1 more source

Home - About - Disclaimer - Privacy